Prosiectau (582)
Cardiff University Schools involved in this Project
Microneedle delivery of antigen-specific immunotherapy for type 1 diabetes (01.10.2014 - 30.09.2018)
- Arikat, Farah
-
- Prokopovich, Polina
3D printing a skin model to investigate immunological control of skin cancer development (01.04.2017 - 31.03.2020)
- Coulman, Sion
Accelerating topical anaesthesia in children (01.04.2015 - 30.09.2015)
- Birchall, James
Access to Phrmy labs (01.04.2008 - 31.10.2011)
Activity of antimicrobial surfaces using the JIS test (19.03.2012 - 22.03.2012)
- Maillard, Jean-Yves
ADC targets from in-silico high throughput screening identification into target validation (01.10.2016 - 21.02.2019)
- Brancale, Andrea
Adherence of C. difficile spores in clinical surfaces (01.01.2017 - 31.03.2017)
- Baillie, Les
ADME studies of fingolimod phosphate prodrugs as promising Niemann-Pick disease treatment (01.09.2018 - 30.11.2018)
- Pertusati, Fabrizio
ADME/toxicology analyses of lead Schistosoma mansoni histone methyltransferase (HMT) inhibitors (30.06.2018 - 21.02.2019)
- Brancale, Andrea
Adsorbent carbons for the removal of biologically active toxins (ACROBAT1) (01.10.2012 - 30.09.2016)
- Baillie, Les
Advanced drug delivery (GALENOS) (01.10.2004 - 30.09.2008)
- Gumbleton, Mark
Advanced Therapeutics Wales (01.07.2018 - 21.02.2019)
- Brancale, Andrea
Advancing analogues of a novel cFlip inhibitor which sensitises breast cancer cells and stem cells to TRAIL (01.10.2015 - 30.09.2016)
- Westwell, Andrew
Advice on formulations (01.03.2011 - 31.03.2011)
- Maillard, Jean-Yves
All Wales antivirals discovery and development platform (01.01.2016 - 31.03.2019)
- Brancale, Andrea
All Wales cellular bioenergetics analysis platform (01.12.2014 - 31.01.2016)
- Mcguigan, Christopher
All Wales cellular bioenergetics analysis platform (01.12.2015 - 30.11.2016)
- Mcguigan, Christopher
ALMOND: Agriculture living machine of operational nano droplets (14.02.2024 - 13.02.2026)
- Castell, Oliver
A microwave powered DNA extraction molecule (01.10.2019 - 01.08.2023)
- Baillie, Les
Analysis of antigen endocytosis (27.08.2018 - 30.11.2018)
- Jones, Arwyn
An antibody based theraphy for Clostridium difficile (01.10.2009 - 30.09.2011)
- Baillie, Les
An assessment using conventional polymer moulding techniques, of sugars, cyclodextrins and natural polyerms for biodegradable microneedle applications (01.10.2008 - 01.07.2012)
- Birchall, James
A natural therapy for bovine tuberculosis and greenhouse gases (01.01.2011 - 31.12.2013)
- Baillie, Les
Ancient-biotics, re-evaluating traditional medicines for future antibacterial therapies (01.08.2016 - 30.11.2016)
- Baillie, Les
An evaluation of outcomes reported by patients with focal hyperhidrosis treated with methanthelinium bromide to support it's reimbursement policy (01.01.2011 - 31.12.2012)
An event to explore Intellectual Property Rights (01.01.2018 - 04.01.2019)
- Brancale, Andrea
An investigation into testing a new class of Chiesi drgs for the treatment of COPD in a model of sub-acute lung inflammation and remodelling - Phase 1 (24.10.2022 - 23.10.2023)
- Ford, William
A novel nanoparticle based real-time sensor for B. anthracis and M. tuberculosis (18.01.2021 - 18.11.2024)
- Baillie, Les
Anthrax environmental decontamination network (01.01.2014 - 31.12.2017)
- Baillie, Les
Antibody-drug conjugates for gyneacolgoical cancer (01.01.2014 - 31.12.2016)
- Mcguigan, Christopher
Anticancer drug discovery (01.10.2008 - 01.06.2010)
- Mcguigan, Christopher
Anti-cancer protides (01.01.2020 - 31.12.2021)
- Slusarczyk, Magdalena
Anti-cancer protides (15.10.2014 - 29.02.2020)
- Slusarczyk, Magdalena
Anti-cancer protides (21.08.2009 - 31.12.2015)
- Mcguigan, Christopher
Anticancer site-specific FAK inhibitors - kinase selectivity profiling (30.06.2018 - 31.10.2018)
- Westwell, Andrew
Anti_CD44 antibody in breast cancer cell lines (01.05.2009 - 01.11.2009)
- Hutcheson, Iain
Anti-HCV Nucleosides (15.11.2007 - 09.10.2013)
- Mcguigan, Christopher
Antimicrobial dermal permeation and pentration (01.08.2015 - 12.09.2015)
Antimicrobial resistance test development (01.10.2010 - 22.06.2012)
- Maillard, Jean-Yves
Antimicrobial workshop in response to MRC call (19.08.2014 - 31.12.2015)
- Mcguigan, Christopher
Antiviral and antibacterial capability of gaseous ozone on mixed surfaces (01.06.2022 - 16.09.2022)
- Baillie, Les
A pilot study to explore the underpinning reasons as to why dissatisfaction within the community pharmacist workforce is higher than in other areas of practice (01.04.2022 - 11.04.2024)
- Davies, Wyn
A Qualitative Study to explore the barriers to engagement with a Physical Health Check in patients with Severe Mental Illness (SMI) (01.04.2022 - 01.04.2024)
- Hodson, Karen
A rapid (10 min), handheld, point of care diagnostic for antibiotic resistant staphylococcus auerus (01.09.2015 - 31.08.2016)
- Baillie, Les
A rapid assay towards detection of Mycobacterium abscesses in clinical sputum samples from patients with cystic fibrosis (01.09.2021 - 28.02.2022)
- Ahortor, Evans
A rapid point of care system to manage/monitor drug treatment in therapeutically relevant mycobacterial infections (01.06.2015 - 31.05.2016)
- Mcguigan, Christopher
A real time, stand alone, portable detector for Bacillus anthracis spores (01.01.2009 - 01.04.2009)
- Baillie, Les
A regulatory working group for microneedle array patches (01.07.2022 - 31.05.2024)
- Coulman, Sion
A review of nebilised formulations (01.11.2013 - 30.11.2013)
-
- Castell, Oliver
ASM Microbe 2018 conference, Atlanta Georgia (01.06.2018 - 30.06.2018)
- Maillard, Jean-Yves
Assessing cellular aging in old and rejuvenated neurons from Alzheimer patients (01.09.2022 - 31.08.2025)
- Newland, Benjamin
Assessment of AKT pathway in patients with hormone receptor positive breast cancer using archived tumour material obtained prior to tamoxifen treatment (01.03.2013 - 28.02.2014)
- Gee, Julia
Assessment of BetterYou's new formulation in terms of the level of calcium permeating skin ex vivo (06.02.2018 - 31.08.2018)
- Heard, Charles
ASTM standard submission for antimicrobial wipes (09.07.2012 - 21.12.2012)
- Maillard, Jean-Yves
A study to evaluate the potential of vectors administered by isolated limb infusion to transduce production and secretion of L-dopa by striated muscle (01.05.2018 - 28.02.2019)
- Lane, Emma
A workshop to develop Welsh capacity for drug lead discovery from natural products (01.04.2014 - 30.09.2015)
- Mcguigan, Christopher
Bacillus anthracis serology study (20.01.2015 - 31.03.2015)
- Baillie, Les
Bacterial-mediated RNA interface as a new therapy to target advanced prostate cancer. (01.10.2014 - 31.01.2016)
- Mcguigan, Christopher
Bacterial resistance to biocides: An assessment of resistance mechanisms and method development (01.10.2011 - 30.09.2015)
- Maillard, Jean-Yves
BeeSound Science Club (01.07.2018 - 31.01.2020)
- Baillie, Les
Bee Well Caerphilly (01.10.2017 - 20.02.2023)
- Baillie, Les
Bench fees (01.10.2015 - 30.09.2017)
- Simons, Claire
Bench fees (21.09.2015 - 30.09.2017)
- Simons, Claire
Beta cell preservation via antigen-specific immunotherapy in type 1 diabetes: Enhanced epidermal antigen delivery systems (01.09.2012 - 31.05.2017)
- Birchall, James
Biocide impregnated surface materials for use in clinical areas - under what conditions do they work? (01.10.2010 - 30.09.2015)
- Maillard, Jean-Yves
Biocompatible 3D printed vasculature for bioprinted tissues (01.02.2024 - 30.11.2024)
- Jamieson, David
Bioengineering of a dual-target therapeutic to modulate a pro-inflammatory and pro-coagulant pathology (01.02.2019 - 30.06.2021)
- Heurich-Sevcenco, Meike
Bio-HhOST: Next Generation 3D Tissue Models: Bio-Hybrid Hierarchical Organoid-Synthetic Tissues (Bio-HhOST) Comprised of Live and Artificial Cells (01.02.2024 - 31.01.2027)
- Castell, Oliver
Biological evaluation of dideoxy bicyclic pyrimidine nucleoside analogues (ddBCNAs) with [L] chirality as novel cell-targeting antivirals active versus measles and other viruses affected by the same MoA (01.04.2015 - 23.12.2018)
- Jones, Arwyn
- Biological evaluation of dideoxy bicyclic pyrimidine nucleoside analogues (ddBCNAs) with [L] chirality as novel cell-targeting antivirals active versus measles and other viruses affected by the same MoA
(01.10.2014 - 29.03.2018)- Jones, Arwyn
Biological investigation of GATA2 inhibition to evaluate its impact on leukaemia blasts and stem cells, and its relevance in therapy (02.01.2024 - 31.12.2024)
- Bassetto, Marcella
Biomaterials and biological interfaces: Towards optimising drug gene delivery (01.04.2009 - 31.08.2010)
- Gumbleton, Mark
Bioresponsive polymer-peptide conjugates for enhanced intracellular delivery of macromolecules (20.09.2006 - 19.06.2010)
- Jones, Arwyn
Brain Games (01.02.2016 - 31.12.2016)
- Jones, Arwyn
British society for nanomedicine early career researchers meeting 2016 (01.06.2016 - 30.11.2016)
- Brancale, Andrea
British society for parasitology spring conference (01.01.2018 - 30.06.2018)
- Brancale, Andrea
Buccal delivery (17.04.2017 - 31.10.2017)
- Heard, Charles
BudSurf Trial - Stability assessment of a Budesonide + Poractant Alfa combination formulation to be used in clinical trial in extreme preterm infants (01.09.2017 - 30.06.2018)
- Birchall, James
CADD Platform (01.11.2016 - 31.10.2017)
- Brancale, Andrea
CALIN (01.09.2016 - 31.08.2023)
- Jones, Arwyn
Cancer diagnosis: parallel sensing of prostate cancer biomarkers (PROSENSE) (01.10.2012 - 30.09.2016)
- Allender, Christopher
Cancer drug discovery: Targeting protein - protein interactions (01.10.2007 - 01.10.2010)
- Westwell, Andrew
Cancer-free future event (01.02.2017 - 31.07.2017)
- Brancale, Andrea
-
- Brancale, Andrea
Caneolin and cancer progression (01.04.2012 - 31.03.2015)
- Gumbleton, Mark
Career progression in drug discovery research (01.01.2017 - 30.06.2017)
- Brancale, Andrea
Cartilage agent delivery (01.08.2014 - 31.10.2015)
- Prokopovich, Polina
Catalytic production of hydrogen peroxide for in situ sterilisation in medical applications (01.04.2016 - 31.10.2020)
- Maillard, Jean-Yves
Catylix: Fluorination strategies for new candidate drugs (01.06.2013 - 31.12.2014)
- Mcguigan, Christopher
Caveolin-1 and glioma tumour initiator cells (01.10.2014 - 30.09.2018)
- Gumbleton, Mark
Caveolin-1 is a key determinant of the stem-like features of RCC (01.10.2011 - 31.12.2014)
- Gumbleton, Mark
CB1: A first-in-class anticancer agent targeting metastatic progenitor cells (13.05.2021 - 31.03.2022)
- Westwell, Andrew
Cell penetrating peptides (02.04.2007 - 02.04.2010)
- Jones, Arwyn
Cellular uptake of drug delivery systems targeting cancer (01.04.2016 - 13.07.2017)
- Jones, Arwyn
Characterisation of novel antimicrobial peptides form the rumen eukaryotome (01.03.2016 - 28.02.2017)
- Mcguigan, Christopher
Characterisation of the human protective immune response to Antrax (01.04.2012 - 31.10.2016)
- Baillie, Les
Characterisation of the immune response to the AVP vaccine (01.07.2009 - 28.02.2010)
- Baillie, Les
Characterising the coagulopathy of obstetric haemorrhage (05.07.2021 - 04.10.2021)
- Heurich-Sevcenco, Meike